drugset / Trial / NCT07239947
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
RandomizedSequentialTriple-blindTreatment
Summary
This is a Phase 1, randomized, blinded, placebo controlled, single ascending dose (SAD) study of BBT001 in healthy volunteers (HVs) and adult patients with moderate to severe Atopic Dermatitis (AD).
Timeline
- Start
- 2025-08-09
- Primary completion
- 2026-08-31
- Completion
- 2027-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BBT001 | Unknown | — | — |